Daily FNArena News - Small Caps

All | Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | Technicals | Treasure Chest

Latest Stories

Woodside Energy warns of constrained near-term cash flow as it approaches peak capital expenditure for growth plans, and outlines intention to increase gas exposure to ensure longer-term growth

Dec 08 2022

Collins Foods has not surprised with its half year result, but updated guidance suggests anticipated second half margin recovery is no longer expected

Dec 01 2022

Actinogen Medical is a biotech with a potentially “gazillion” dollar opportunity in its Alzheimer’s drug

Nov 30 2022

A turn in sentiment has allowed Nanosonics shares to recover, with (some) broker views turning less negative

Nov 29 2022

Previous Stories

Headwinds Linger for Select Harvests

Nov 24 2022

The headwinds that drove a soft FY22 for Select Harvests look to continue to challenge the company in the new fiscal year

United Malt Guides To Better Times Ahead

Nov 23 2022

United Malt’s FY22 was weak, as expected, but the company has guided to significant earnings growth ahead

Nufarm Confident About Continued Growth

Nov 22 2022

Nufarm wraps up a strong year with guidance for modest growth ahead, surprising analysts who had largely predicted an earnings decline

Elders’ Confidence Relies On Acquisition

Nov 16 2022

Elders closes the year on a strong note, but heavy rainfall dampens the outlook for coming harvests

Dr Boreham’s Crucible: Mach7 Technologies

Nov 14 2022

Medical imaging is back in demand in the post-covid world and Mach7 Technologies seems an undervalued player

Dr Boreham’s Crucible: Qbiotics Group

Nov 09 2022

Having brought a canine cancer treatment to market, Qbiotic’s focus has returned to treating two-legged cancers including melanoma and other difficult-to-treat cancers

Poor Production Won’t Rain On Coronado’s Parade

Nov 02 2022

Despite a weaker production result in its third quarter, Coronado Resources has benefitted from strong price realisation

Cash Is King For Small Caps

Oct 31 2022

Tim Boreham notes small caps with cash on the balance sheet are the safer bet compared to ‘pre-revenue’ companies, and highlights several examples

Valuation The Issue For Pilbara Minerals

Oct 27 2022

A solid first quarter has not been enough for analysts to find upside value in Pilbara Minerals

Dr Boreham’s Crucible: Imricor Medical Systems

Oct 17 2022

Imricor is a player in a global catheter ablation market worth $US5.5 billion and growing at a compound rate of just over 8% a year

Analyse The Market From A Different Angle